SureTrader Stock Hero Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs > Cellular Biomedicine Group, Inc. (CBMG)

EastBridge Investment Group's Wholly Owned Subsidiary, General Farms

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
pappi Member Profile
Member Level 
Followed By 8
Posts 1,584
Boards Moderated 0
Alias Born 01/11/04
160x600 placeholder
Advertisement
Cellular Biomedicine Group to Present at 10th Annual World Stem Cells & Regenerative Medicine Congress in London, UK "GlobeNewswire Inc." - 4/17/2015 9:15:00 AM
Cellular Biomedicine Group Announces Participation in Jefferies 2015 Global Healthcare Conference "GlobeNewswire Inc." - 4/16/2015 7:30:00 AM
Cellular Biomedicine Group Inc. Investors Encouraged to Contact Securities Law Firm about Investigation into Allegations of C... "PR Newswire (US)" - 4/15/2015 11:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/15/2015 6:04:05 AM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/13/2015 6:10:27 AM
Cellular Biomedicine Group to Present at ChinaBio(R) Partnering Forum in Shanghai on April 16, 2015 "GlobeNewswire Inc." - 4/10/2015 9:30:00 AM
Cellular Biomedicine Group Upgraded to NASDAQ Global Market "GlobeNewswire Inc." - 4/10/2015 7:30:00 AM
Cellular Biomedicine Group Hosts Open House Titled "Advancing Solutions to Cancerous and Degenerative Straits" on April 17, 2... "GlobeNewswire Inc." - 4/8/2015 12:01:01 PM
Cellular Biomedicine Group Responds to False Statements and Allegations Made by Short Seller "GlobeNewswire Inc." - 4/8/2015 9:52:09 AM
Peiffer Rosca Wolf Abdullah Carr & Kane Announces Investigation on Behalf of Cellular Biomedicine Group Inc. Stockholders "Business Wire" - 4/7/2015 6:00:00 PM
Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Cellular Biomedicine Group Inc. "PR Newswire (US)" - 4/7/2015 4:30:00 PM
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellular Biomedicine Group Inc. - CBMG "PR Newswire (US)" - 4/7/2015 4:26:00 PM
Scott+Scott, Attorneys at Law, LLP Announces Investigation of Cellular Biomedicine Group Inc. "Business Wire" - 4/7/2015 3:11:00 PM
The Rosen Law Firm Announces Investigation of Securities Claims Against Cellular Biomedicine Group Inc. – CBMG "Business Wire" - 4/7/2015 1:36:00 PM
Cellular Biomedicine Group Announces Closing of $19.6 Million Private Placement Offering "GlobeNewswire Inc." - 4/7/2015 9:30:12 AM
Midday Gainers / Losers "Seeking Alpha" - 4/6/2015 12:44:45 PM
Cellular Biomedicine Group's Shanghai Facility Passes Fourth Consecutive CFDA Inspection "GlobeNewswire Inc." - 4/6/2015 9:00:00 AM
Cellular Biomedicine beats on revenue "Seeking Alpha" - 3/31/2015 8:54:31 AM
Cellular Biomedicine Group Reports Full-Year and Fourth Quarter 2014 Financial Results "GlobeNewswire Inc." - 3/31/2015 8:46:36 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/31/2015 8:21:05 AM
Cellular Biomedicine Group Announces Interim Results From Phase IIb Clinical Trial for Knee Osteoarthritis Stem Cell ReJoin(T... "GlobeNewswire Inc." - 3/25/2015 9:00:00 AM
Cellular Biomedicine Group Announces Phase I Results From CAR-T Immuno-Oncology Clinical Development Programs "GlobeNewswire Inc." - 3/25/2015 9:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/25/2015 8:56:02 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/25/2015 8:53:22 AM
Cellular Biomedicine Group to Present Osteoarthritis Stem Cell Rejoin(TM) Therapy and Cancer CAR-T Therapy Clinical Developme... "GlobeNewswire Inc." - 3/18/2015 9:22:41 AM
pappi Member Level  Wednesday, 12/05/07 01:12:37 PM
Re: None
Post # of 2712 
EastBridge Investment Group's Wholly Owned Subsidiary, General Farms Corp, to Be Acquired by Rhino Two Horns, Malaysia
Wednesday December 5, 8:00 am ET


PHOENIX, AZ--(MARKET WIRE)--Dec 5, 2007 -- EastBridge Investment Group (EBIG) (OTC BB:EBIG.OB - News) today announced that it has signed a definitive agreement with Rhino Two Horns Sdn. Bhd, Malaysia for it to acquire General Farms Corp and assume effective control.

General Farms is a wholly owned subsidiary of EastBridge. A stock dividend of 5% of General Farm's common stock, or 10,000,000 shares, will be distributed to EastBridge's shareholders of record as of Nov 16, 2007. Under the terms of the share exchange agreement, the new stock ownership structure is: 15% owned by EastBridge and 5% owned by EastBridge's shareholders of record as of Nov 16, 2007. Rhino's beneficiaries will own the remaining 80%. The closing is expected to happen in ten working days.

Mr. Norm Klein, COO and CFO of EastBridge, commented, "We are committed to taking Rhino Two Horns Sdn. Bhd, Malaysia public in the U.S. as soon as practicable in 2008. We are quite impressed with the progress made by Rhino's management since August, 2007."

Rhino Two Horns, based in Malaysia, is first to market all natural energy sports drinks containing a unique formulation that re-hydrates faster than water and assists the body to refresh and recover from intense sporting activities in the sub-tropical climates. The current TWO HORNS(TM) product range includes Energy 250, and Ultra Sports 500 beverages. New products featuring the 'super fruit' Acai berry, called Acai Energy 250 and R3HYDR8(TM) 250 are being prepared for launch in the 1st quarter 2008. The company is currently negotiating to market its products to China, U.S. and Sri Lanka. More information is available at www.rhinotwohorns.com.

EastBridge Investment Group focuses on small to medium-size high-growth companies in China and India offering IPOs, Joint Ventures and Merchant Banking services. The Company targets industries in electronics, real estate, auto, metal, energy, environmental, bioscience and food retail distribution. To learn more about EastBridge Investment Group go to our web site: www.EbigCorp.com. To receive EBIG's email alert, send a blank email to info@EbigCorp.com.

The information in this news release includes certain forward-looking statements that are based upon assumptions that in the future may prove not to have been accurate and are subject to significant risks and uncertainties, including statements to the future financial performance of the Company. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it can give no assurance that such expectation or any of its forward-looking statements will prove to be correct. Factors that could cause results to differ include, but are not limited to, successful performance of internal plans, fluctuations in foreign currency exchange, the impact of competitive services and pricing, or general economic risks and uncertainties.



Contact:
Company Contact:
Norm Klein
EastBridge Investment Group Corp.
480-966-2020
480-966-0808 (fax)
Email Contact

Investor Relations Contact:
Jack Eversull
The Eversull Group, Inc.
972-378-7917
972-378-7981 (fax)
Email Contact



--------------------------------------------------------------------------------
Source: EastBridge Investment Group



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist